Volv Global joins Innovaud, One Nucleus & ARC West London to explore innovation and investment opportunities across the Lausanne London life sciences corridor.
When science fiction becomes science fact: AI for rare disease diagnosis – how Volv Global's work moves us from the imaginable to operational reality.
Explore Volv Global’s ISPOR 2026 research with Sanofi on Pompe disease, based on use of machine learning-driven endpoint discovery on real-world data
Repeated steroid use in IBD care signals failing treatment pathways. Learn why steroid exposure is a key red flag and how to improve patient outcomes.
Discover how patient advocacy accelerates rare disease diagnosis and innovation, bringing technology, real-world data, and collaboration together to improve care.
Guest article by Rareatives reflecting on Rare Disease Day and why awareness, patient stories, and advocacy play a vital role in supporting the rare disease community.
